Dasatinib and Acyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dasatinib (dasatinib) and Acyclovir (acyclovir). Common drug interactions include graft versus host disease among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Dasatinib and Acyclovir. It is created by eHealthMe based on reports of 80 people who take the same drugs from the FDA, and is updated regularly.

What is Dasatinib?

Dasatinib has active ingredients of dasatinib. eHealthMe is studying from 9,407 Dasatinib users. Check the latest studies of Dasatinib.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

80 people who take Dasatinib and Acyclovir together, and have interactions are studied.

Dasatinib and Acyclovir drug interactions.

What are the common drug interactions of Dasatinib and Acyclovir, by gender? *:

female:

Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hepatic enzyme increased
Hypoaesthesia (reduced sense of touch or sensation)
Muscular weakness (muscle weakness)
Myopathy (a muscular disease in which the muscle fibres do not function)
Pain
Petechiae (a small red or purple spot caused by bleeding into the skin)
Purpura (purplish discoloration of the skin)
Wheezing (a high-pitched whistling sound made while you breath)
Abdominal pain

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Pneumonia
Rash
Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Duodenal polyp (duodenal epithelial tumours)
Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hepatotoxicity (chemical-driven liver damage)
Hydronephrosis (water inside the kidney)
Inflammation

What are the common drug interactions of Dasatinib and Acyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Arthralgia (joint pain)
Bone pain
Sepsis (a severe blood infection that can lead to organ failure and death)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Respiratory failure (inadequate gas exchange by the respiratory system)
Pneumonia
Renal failure (kidney dysfunction)
Disease progression
Cardiovascular disorder (heart diseases)
Neutropenia (an abnormally low number of neutrophils)

10-19:

Cytomegalovirus infection
Drug hypersensitivity
Escherichia sepsis (bacterial infection by escherichia coli)
Eye swelling
Fluid overload (too much fluid in the blood)
Gastritis (inflammation of stomach)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Lymphadenopathy (disease or enlargement of lymph nodes)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Pericardial haemorrhage (bleeding into the heart)

20-29:

Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Cerebral venous thrombosis (clot in brains venous blood system)
Drug ineffective
Eating disorder
Fatigue (feeling of tiredness)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
Haematochezia (passage of stools containing blood)
Large intestinal ulcer
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)

30-39:

Acute hepatic failure
Adverse event
Infection

40-49:

Drug ineffective
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)
Aplasia (defective development or congenital absence of an organ or tissue)
Acarodermatitis (skin inflammation caused by mites (acarids))
Anxiety
Asthenia (weakness)
Blood potassium increased
Decreased appetite
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Abdominal pain
Cardiomyopathy (weakening of the heart muscle)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Death
Dyspnoea (difficult or laboured respiration)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Cytomegalovirus enterocolitis (virus infection of intestine and colon)

60+:

Pleural effusion (water on the lungs)
Pericardial effusion (fluid around the heart)
Leukaemia (blood or bone marrow cancer)
Leukocytosis (increased white blood cells)
Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
Malignant neoplasm progression (cancer tumour came back)
Pallor
Syncope (loss of consciousness with an inability to maintain postural tone)
Upper respiratory tract infection
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 21 people, 26.25%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 11 people, 13.75%
Leukaemia (blood or bone marrow cancer): 7 people, 8.75%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 7.50%
Thrombocytopenia (decrease of platelets in blood): 4 people, 5.00%
Nausea (feeling of having an urge to vomit): 4 people, 5.00%
Fever: 4 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dasatinib and Acyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously